Dr. Jill Shukla’s journey in the pharmaceutical industry is a testament to resilience, innovation, and leadership. As the Founder and Director of Volonium Pharma, she has successfully bridged the gap between groundbreaking research and real-world healthcare solutions, establishing herself as a pioneer in the field.

Armed with a Ph.D. in Pharmaceutics from Gujarat Technological University and expertise in regulatory affairs and intellectual property, she built Volonium Pharma with a clear vision—to revolutionize pharmaceutical R&D and manufacturing. With state-of-the-art facilities in Bardoli, Gujarat, and Edison, New Jersey, Volonium has been at the forefront of pharmaceutical innovation, catering to both domestic and international markets.

Her ability to transform research into market-ready solutions has been widely recognized. In 2021, The CEO Magazine honored her as one of the “20 Most Reputed Business Leaders in the Pharmaceutical and Lifescience Industry.” The same year, her insights on the future of R&D were featured in an exclusive interview conducted by CPHI Worldwide. A strong advocate for women’s leadership in the healthcare sector, she was awarded membership in the Healthcare Businesswomen’s Association in the USA in 2022.

Her contributions have not only been recognized in India but also on a global scale. In 2024, she was interviewed by Marquis Who’s Who, New York, for her outstanding contributions to the industry. Her excellence was further acknowledged in 2025 when she received the “Women of Excellence” award from the All-India Business & Community Foundation.

As an advisory board member at Cambridge Publishing Scholars, London, she continues to shape the future of pharmaceutical research. Her relentless pursuit of innovation has positioned Volonium as a leader in the industry, embodying its guiding principle: “The New Innings of Success Through Innovation in Healthcare.”